InvestSMART

Bod Science Limited (ASX: BOD) - Announcements

DELISTED - Current share price for BOD : $0.024

ASX company news and announcements for Bod Science Limited (BOD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bod Science Limited (BOD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bod Science Limited (BOD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bod Science Limited (BOD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Preliminary Final Report 12 Aug 2008 2:14PM n/a $0.024 n/a
- Appendix 4C - quarterly 22 Jul 2008 10:08AM n/a $0.024 n/a
- First human implant of cardiocel adapt biomaterial patches 1 May 2008 12:52PM n/a $0.024 n/a
- Appendix 4C - quarterly 11 Apr 2008 10:16AM n/a $0.024 n/a
- TGA Inclusion 7 Mar 2008 12:26PM $0.105 $0.024 fallen by 77.14%
- Half Yearly Report and Accounts 12 Feb 2008 12:24PM n/a $0.024 n/a
- Appendix 4C - quarterly 15 Jan 2008 10:14AM $0.100 $0.024 fallen by 76%
- TGA Certificate 6 Dec 2007 11:46AM n/a $0.024 n/a
- Agreement signed with Royal Perth Hospital 13 Nov 2007 10:47AM $0.105 $0.024 fallen by 77.14%
- Quarterly Activities Report 17 Oct 2007 1:47PM $0.120 $0.024 fallen by 80%
- Positive results from a 12 month comparative patch study 10 Sep 2007 11:14AM $0.110 $0.024 fallen by 78.18%
- Positive results from a 12 month comparative patch study 10 Sep 2007 11:14AM $0.110 $0.024 fallen by 78.18%
- Preliminary Final Report 28 Aug 2007 3:06PM $0.150 $0.024 fallen by 84%
- Non-Renounceable Issue Prospectus 22 Aug 2007 6:39PM $0.140 $0.024 fallen by 82.86%
- New Issue of Securities 9 Aug 2007 1:10PM $0.140 $0.024 fallen by 82.86%
- Appendix 4C - quarterly 16 Jul 2007 1:29PM $0.145 $0.024 fallen by 83.45%
- Approval for human clinical trial of Adapt cardio patches 12 Jul 2007 11:09AM $0.155 $0.024 fallen by 84.52%
- Human Clinical Trial of Adapt Treated Cardiovascular Patches 30 May 2007 10:07AM $0.115 $0.024 fallen by 79.13%
- Acquires Additional Holding in Celxel P/L 8 May 2007 10:17AM $0.105 $0.024 fallen by 77.14%
- Commitments Test Entity - Third Quarter Report 17 Apr 2007 1:15PM n/a $0.024 n/a
- Positive results from a 200 day comparative patch study 14 Mar 2007 4:08PM n/a $0.024 n/a
- Half Yearly Report & Half Year Accounts 2 Feb 2007 10:10AM $0.160 $0.024 fallen by 85%
- Commitments Test Entity - Second Quarter Report 17 Jan 2007 11:55AM $0.140 $0.024 fallen by 82.86%
- Promising preclinical results ADAPT patch and graft trial 16 Jan 2007 10:20AM $0.185 $0.024 fallen by 87.03%
- Commitments Test Entity - First Quarter Report 23 Oct 2006 3:12PM $0.110 $0.024 fallen by 78.18%

251 - 275 of 298 results

Page 11 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.